H Tsuda Selected Research

H Tsuda Research Topics

Disease

48	Neoplasms (Cancer) 10/2016 - 01/2000
17	Breast Neoplasms (Breast Cancer) 09/2013 - 01/2000
14	Carcinoma (Carcinomatosis) 08/2010 - 01/2000
12	Carcinogenesis 10/2006 - 01/2000
9	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2000
8	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 09/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016 - 05/2009
4	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 02/2000
4	Ductal Carcinoma 08/2011 - 02/2000
3	Lymphatic Metastasis 01/2015 - 09/2013
3	Residual Neoplasm 09/2013 - 10/2000
3	Lung Neoplasms (Lung Cancer) 01/2013 - 01/2000
3	Necrosis 12/2012 - 10/2000
3	Adenocarcinoma 05/2009 - 04/2000
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2004 - 11/2001
2	Squamous Cell Carcinoma of Head and Neck 10/2016 - 08/2010
2	Inflammation (Inflammations) 01/2015 - 04/2013
2	Fibrosis (Cirrhosis) 09/2013 - 10/2000
2	Neuroendocrine Carcinoma 01/2012 - 07/2001
2	Ovarian Epithelial Carcinoma 01/2012 - 01/2010
2	Uterine Neoplasms (Uterine Cancer) 01/2011 - 11/2008
2	Fever (Fevers) 01/2007 - 05/2001
2	Glioma (Gliomas) 07/2004 - 11/2000
2	Aberrant Crypt Foci 07/2004 - 01/2000
2	Aneuploidy (Aneuploid) 10/2001 - 01/2001
2	Hyperplasia 06/2001 - 04/2000
2	Endometrial Hyperplasia 06/2001 - 02/2000
2	Protein S Deficiency (Deficiency, Protein S) 05/2001 - 03/2001
2	Thrombosis (Thrombus) 05/2001 - 03/2001
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2001 - 01/2000
1	Starvation 06/2017
1	Lung Injury 01/2015
1	Triple Negative Breast Neoplasms 10/2014
1	Placenta Previa 06/2014
1	Placenta Accreta 06/2014
1	Infarction (Infarctions) 03/2014
1	Stroke (Strokes) 03/2014
1	Extramammary Paget Disease (Paget Disease, Extramammary) 06/2013

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2000
7	DNA (Deoxyribonucleic Acid)IBA 05/2005 - 04/2000
6	LactoferrinIBA 10/2000 - 01/2000
4	PlatinumIBA 02/2015 - 01/2007
4	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 11/2001
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 09/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2007 - 01/2001
4	Estrogen ReceptorsIBA 05/2001 - 01/2000
3	CarcinogensIBA 09/2013 - 01/2000
3	ErbB Receptors (EGF Receptor)IBA 06/2013 - 01/2001
3	Monoclonal AntibodiesIBA 01/2013 - 07/2000
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2012 - 09/2004
3	Hormones (Hormone)IBA 08/2011 - 01/2000
3	Messenger RNA (mRNA)IBA 10/2006 - 04/2001
3	Docetaxel (Taxotere)FDA Link 10/2005 - 01/2001
3	Codon (Codons)IBA 06/2001 - 02/2000
3	AzoxymethaneIBA 04/2001 - 01/2000
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2001 - 01/2000
3	ErbB-2 ReceptorIBA 01/2001 - 01/2000
3	EnzymesIBA 07/2000 - 01/2000
2	Butyrates (Butyrate)IBA 06/2017 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 10/2014 - 12/2005
2	AcidsIBA 08/2010 - 04/2000
2	Trastuzumab (Herceptin)FDA Link 07/2010 - 01/2001
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2007 - 09/2004
2	Platinum Compounds (Compounds, Platinum)IBA 01/2007 - 09/2004
2	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2001 - 01/2000
2	Keratins (Keratin)IBA 10/2001 - 01/2001
2	ParaffinIBA 10/2001 - 09/2001
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 06/2001 - 02/2000
2	AS 8IBA 06/2001 - 02/2000
2	Protein SIBA 05/2001 - 03/2001
2	Connexin 43 (Connexin43)IBA 11/2000 - 01/2000
2	ConnexinsIBA 11/2000 - 01/2000
2	Drinking WaterIBA 07/2000 - 01/2000
1	Histone Deacetylases (Histone Deacetylase)IBA 06/2017
1	ChromatinIBA 06/2017
1	Factor VaIBA 10/2016
1	hypusineIBA 10/2016
1	deoxyhypusine synthaseIBA 10/2016
1	CaspasesIBA 02/2015
1	LipopolysaccharidesIBA 01/2015
1	HydrogenIBA 01/2015
1	Nucleic AcidsIBA 09/2013
1	human ERBB2 proteinIBA 06/2013
1	LipidsIBA 04/2013
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2013

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2017 - 10/2000
10	Therapeutics 01/2015 - 01/2000
5	Neoadjuvant Therapy 07/2010 - 10/2000
2	Combination Drug Therapy (Combination Chemotherapy) 01/2007 - 09/2004
2	Radiotherapy 08/2001 - 07/2001
2	Conservative Treatment 06/2001 - 05/2001
2	Aftercare (After-Treatment) 05/2001 - 01/2001
2	Oral Administration 10/2000 - 01/2000
2	Chemoprevention 04/2000 - 01/2000
1	CP protocol 01/2015
1	Adjuvant Chemotherapy 10/2014
1	Suture Techniques 06/2014
1	Cesarean Section (Caesarean Section) 06/2014
1	Sutures (Suture) 06/2014
1	Intravenous Administration 03/2014